Bifidobacterium in the treatment of inflammatory disease

John Kevin Collins; Gerald Christopher O'Sullivan; Liam O'Mahony; Fergus Shanahan

Bifidobacterium in the treatment of inflammatory disease

John Kevin Collins
, Gerald Christopher O'Sullivan
, Liam O'Mahony
, Fergus Shanahan

School of Medicine

Research output: Contribution to journal › Article

Abstract

A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.

Original language	English (Ireland)
Journal	United States Patent
Volume	2
Issue number	12
Publication status	Published - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{5c91c213083b4cada33f00f5419ce1e8,

title = "Bifidobacterium in the treatment of inflammatory disease",

abstract = "A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.",

author = "Collins, \{John Kevin\} and O'Sullivan, \{Gerald Christopher\} and Liam O'Mahony and Fergus Shanahan",

year = "2007",

language = "English (Ireland)",

volume = "2",

journal = "United States Patent",

number = "12",

}

TY - JOUR

T1 - Bifidobacterium in the treatment of inflammatory disease

AU - Collins, John Kevin

AU - O'Sullivan, Gerald Christopher

AU - O'Mahony, Liam

AU - Shanahan, Fergus

PY - 2007

Y1 - 2007

N2 - A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.

AB - A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.

UR - https://www.mendeley.com/catalogue/a91fa4fe-8b04-3e5d-bf18-e2df5659dd22/

M3 - Article

VL - 2

JO - United States Patent

JF - United States Patent

IS - 12

ER -

Bifidobacterium in the treatment of inflammatory disease

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this